Nasdaq

FDA Approves JUVÉDERM® VOLUX™ XC for Improvement of Jawline Definition

JUVÉDERM® VOLUX™ XC IS THE FIRST AND ONLY HYALURONIC ACID (HA) FILLER TO RECEIVE U.S. FDA APPROVAL FOR IMPROVING JAWLINE DEFINITION IRVINE, Calif., Aug. 3, 2022 /PRNewswire/ -- Today, Allergan ...
Healthline

Restylane and Juvederm Lip Fillers

Restylane and Juvederm are hyaluronic acid-containing dermal fillers used to plump up the skin and reduce the appearance of wrinkles. These are nonsurgical (noninvasive) procedures. Restylane Silk is ...
Pharm Exec

FDA Approves AbbVie’s Juvederm Voluma XC for the Treatment of Moderate to Severe Temple Hollowing

This marks the first time that a hyaluronic acid dermal filler has received FDA approval for temple hollowing. Allergan Aesthetics, an AbbVie company, announced that the FDA has approved Juvéderm ...
Business Wire

ADDING MULTIMEDIA FDA Approves JUVÉDERM VOLUMA™ XC

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc., (NYSE:AGN) today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLUMA™ XC, the ...
The Financial

JUVÉDERM VOLBELLA XC Approved By U.S. FDA For Use In Lips And Perioral Rhytids

The FINANCIAL — Allergan plc, on June 1 announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLBELLA XC, for use in the lips for lip ...
People

We Tried It: Juvederm Volbella XC, a New Lip Injection That Lasts a Whole Year

One editor tried lip injections -- and here's her story What It Is: Juvederm Volbella XC, a new lip-injection gel that uses a mixture of hyaluronic acid said to last a full year — way longer than ...
Stockhouse

JUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA Approval

IRVINE, Calif., March 5, 2024 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of JUVÉDERM® VOLUMA® XC for injection in the ...